Javier Gómez‐Román

4.1k total citations · 1 hit paper
140 papers, 2.9k citations indexed

About

Javier Gómez‐Román is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Javier Gómez‐Román has authored 140 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 36 papers in Oncology. Recurrent topics in Javier Gómez‐Román's work include Lung Cancer Treatments and Mutations (14 papers), Transplantation: Methods and Outcomes (11 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Javier Gómez‐Román is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Transplantation: Methods and Outcomes (11 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Javier Gómez‐Román collaborates with scholars based in Spain, United States and France. Javier Gómez‐Román's co-authors include J. Fernando Val‐Bernal, Angelita Rebollo, Francisco Leyva‐Cobián, Pablo Sánchez‐Velasco, Carlos Martı́nez-A, Gonzalo Ocejo-Vinyals, Claudia Lebedinsky, Sant P. Chawla, Yusri Elsayed and Alphonse Garcı́a and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Javier Gómez‐Román

132 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

2009 397 citations Javier Gómez‐Román et al. profile →

Peers

Countries citing papers authored by Javier Gómez‐Román

Since Specialization

Citations

This map shows the geographic impact of Javier Gómez‐Román's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Gómez‐Román with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Gómez‐Román more than expected).

Fields of papers citing papers by Javier Gómez‐Román

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Gómez‐Román. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Gómez‐Román. The network helps show where Javier Gómez‐Román may publish in the future.

Co-authorship network of co-authors of Javier Gómez‐Román

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Gómez‐Román. A scholar is included among the top collaborators of Javier Gómez‐Román based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Gómez‐Román. Javier Gómez‐Román is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men 2025 ·BJUI Compass ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Javier Gómez‐Román, (unknown), (unknown), (unknown), Félix Campos‐Juanatey, Maria Teresa Garcı́a-Unzueta, J.L. Gutiérrez Baños	1
2	Flecainide-associated Pneumonitis, a Case Report: COVID is Not All That it Seems 2024 ·SHILAP Revista de lepidopterología ·Diego Ferrer‐Pargada, David Iturbe‐Fernández, (unknown), (unknown), (unknown), (unknown), Javier Gómez‐Román	0
3	Usefulness of COL11A1 as a Prognostic Marker of Tumor Infiltration 2023 ·Biomedicines ·Javier Freire, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Javier Gómez‐Román	3
4	New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology 2022 ·Clinical & Translational Oncology ·Dolores Isla, María D. Lozano, Luis Paz‐Ares, Clara Salas, Javier de Castro, Esther Conde, Enriqueta Felip, Javier Gómez‐Román, Pilar Garrido, Ana B. Enguita	23
5	Double-Lung Transplantation in a Patient with Pulmonary Type B Niemann-Pick Disease: A Valid Treatment Option 2022 ·SHILAP Revista de lepidopterología ·Víctor Manuel Mora Cuesta, (unknown), David Iturbe‐Fernández, (unknown), (unknown), (unknown), Javier Gómez‐Román, José M. Cifrián	2
6	ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer 2021 ·Oncogene ·Thaidy Moreno-Rodriguez, (unknown), Laura González-Silva, (unknown), Carlos Revilla, Antonio Agraz-Doblás, Javier Freire, (unknown), (unknown), Rosa Blanco, Santiago Montes‐Moreno, Laura Cereceda, Aurora Astudillo, Berta Casar, Piero Crespo, Cristina Morales, Paola Scaffidi, Javier Gómez‐Román, Eduardo Salido, Ignacio Varela	24
7	Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review 2020 ·Journal of Clinical Medicine ·Belén Atienza‐Mateo, Sara Remuzgo‐Martínez, D. Prieto-Peña, Víctor Manuel Mora Cuesta, David Iturbe‐Fernández, Javier Llorca, (unknown), Alfonso Corrales, (unknown), Javier Gómez‐Román, José M. Cifrián, Miguel Á. González‐Gay	23
8	A proliferation‐inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients 2019 ·Clinical Transplantation ·(unknown), Adalberto Benito‐Hernández, David San Segundo, (unknown), (unknown), Javier Gómez‐Román, Gema Fernández‐Fresnedo, Marcos López‐Hoyos, Juan Carlos Ruiz, Emilio Rodrigo	21
9	¿Es posible predecir la evolución de la nefropatia IgA? Validamos la calculadora de progresión de nefropatia IgA y su relación con Oxford score en nuestra población 2019 ·Nefrología ·(unknown), Adalberto Benito, (unknown), (unknown), Javier Martín-López, Javier Gómez‐Román, Raquel López‐Mejías, Gema Fernández‐Fresnedo, Juan Carlos Ruiz, (unknown)	4
10	The genetic profile of bone marrow transplant patients in different samples of forensic interest 2018 ·Forensic Science Medicine and Pathology ·(unknown), Ana Santurtún, Javier Freire, Javier Gómez‐Román, (unknown), Marı́a T. Zarrabeitia	3
11	Gold glyconanoparticles coupled to listeriolysin O 91–99 peptide serve as adjuvant therapy against melanoma 2017 ·Nanoscale ·Ricardo Calderón-González, (unknown), Isabel Garcı́a, Marco Marradi, (unknown), (unknown), (unknown), (unknown), (unknown), Almudena García‐Castaño, Javier Gómez‐Román, Soledad Penadés, Fernando Rivera, Javier Freire, (unknown)	18
12	PRODUCCIÓN Y CARACTERIZACIÓN DE POLIHIDROXIALCANOS A PARTIR DE RESIDUOS AGROINDUSTRIALES 2017 ·Vitae (Universidad de Antioquia) ·(unknown), Javier Gómez‐Román, (unknown), (unknown), (unknown), (unknown), (unknown), Mauricio Marín Montoya	1
13	Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer 2014 ·Cancer Discovery ·Elza C. de Bruin, Catherine Cowell, Patricia H. Warne, Ming Jiang, Rebecca E. Saunders, Mary Ann Melnick, Scott Gettinger, Zenta Walther, Anna Wurtz, Guus J.J.E. Heynen, Daniëlle A.M. Heideman, Javier Gómez‐Román, Almudena García‐Castaño, Yixuan Gong, Marc Ladanyi, Harold Varmus, René Bernards, Egbert F. Smit, Katerina Politi, Julian Downward	154
14	Isolated pulmonary vasculitis: Case report and literature review 2014 ·Seminars in Arthritis and Rheumatism ·Leyre Riancho‐Zarrabeitia, Felipe Zurbano, Javier Gómez‐Román, (unknown), (unknown), Miguel A. Hernández‐Hernández, Trinitario Pina, Miguel Á. González‐Gay	14
15	Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies 2010 ·Drug Metabolism and Disposition ·Upendra A. Argikar, Javier Gómez‐Román, (unknown), Henry P. Parkman, Swati Nagar	24
16	Enfermedad luxante de la cadera: aspectos epidemiológicos, clínicos y terapéuticos: utilidad de la ecografía como método de screening 2009 ·Anales del Sistema Sanitario de Navarra ·(unknown), (unknown), Javier Gómez‐Román, (unknown), (unknown), (unknown), Félix Sánchez‐Valverde	0
17	Everolimus-related Pulmonary Toxicity in Heart Transplant Recipients 2008 ·The Journal of Heart and Lung Transplantation ·Víctor Expósito, José A. Vázquez de Prada, Javier Gómez‐Román, Francisco González-Vílchez, (unknown), Tamara García Camarero, (unknown), Javier Ruano, Rafael Martín‐Durán	39
18	Fibroblast Growth Factor Receptor 3 Is Overexpressed in Urinary Tract Carcinomas and Modulates the Neoplastic Cell Growth 2005 ·Clinical Cancer Research ·Javier Gómez‐Román, Pilar Sáenz, (unknown), (unknown), Simon Santa Cruz, (unknown), Laureano Simón, Antonio Martı́nez, J.L. Gutiérrez Baños, M. López-Brea, (unknown), J. Fernando Val‐Bernal	100
19	Primary lymphoplasmacytoid lymphoma of the trachea with immunoglobulin G paraprotein 1999 ·Pathology International ·Javier Gómez‐Román, (unknown), (unknown), (unknown), J Baró, J. Fernando Val‐Bernal	12
20	Bronchiolitis Obliterans and IgA Nephropathy 1997 ·American Journal of Respiratory and Critical Care Medicine ·José L. Hernández, Javier Gómez‐Román, Emilio Rodrigo, José M. Olmos, Carmen González‐Vela, Juan Carlos Ruiz, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact